Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/1780 stock hub

TPEX/1780 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/1780is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/1780

In the news

Latest news · TPEX/1780

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E23.8

P25 14.4P50 18P75 31.9

ROE10.7

P25 -16.2P50 0.3P75 9.8

ROIC8.4

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/1780 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

TWD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	40
Enterprise value	TWD 2.9B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0001780005
Last refreshed	2026-05-10
Market cap	TWD 3.1B
Price	TWD 31.85
Price currency	TWD
Rev Per Employee	21,237,675x
Sector	Healthcare
Sic	2833
Symbol	tpex/1780
Website	https://www.altratene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.22%
EV Earnings	22.74x
EV/EBIT	24.46x
EV/EBITDA	16.23x
EV/FCF	23.06x
EV/Sales	3.46x
FCF yield	4.16%
P/B ratio	2.48x
P/E ratio	23.77x
P/S ratio	3.61x
PE Ratio10 Y	24.89x
PE Ratio3 Y	17.25x
PE Ratio5 Y	24.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.17%
EBITDA Margin	20.69%
FCF margin	15.02%
Gross margin	36.33%
Gross Profit	TWD 308.6M
Gross Profit Growth	19.44%
Gross Profit Growth Q	15.55%
Gross Profit Growth3 Y	4.42%
Gross Profit Growth5 Y	5.06%
Net Income	TWD 129.5M
Net Income Growth	28.25%
Net Income Growth Q	252.55%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	-4.09%
Net Income Growth5 Y	10.25%
Pretax Margin	19.32%
Profit Margin	15.24%
Profit Per Employee	TWD 3.2M
Profitable Years	18
ROA	3.46
Roa5y	2.85
ROCE	9.32
ROE	10.65
Roe5y	8.32
ROIC	8.43
Roic5y	6.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.35%
Cagr15y	10.13%
Cagr1y	91.11%
Cagr3y	24.21%
Cagr5y	18.04%
Div CAGR3	-5.9%
Div CAGR5	4.56%
EPS Growth	27.62
EPS Growth Q	255.2
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	-4.32
EPS Growth5 Y	10.05
FCF Growth	-35.21%
FCF Growth Q	-34.75%
FCF Growth3 Y	5.2%
FCF Growth5 Y	116.94%
OCF Growth	-2.98%
OCF Growth Q	130.12%
OCF Growth10 Y	7.86%
OCF Growth3 Y	9.74%
OCF Growth5 Y	29.56%
Revenue Growth	5.28x
Revenue Growth Q	14.88x
Revenue Growth Quarters	9x
Revenue Growth Years	5x
Revenue Growth3 Y	5.83x
Revenue Growth5 Y	6.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.39
Assets	TWD 2.1B
Cash	TWD 853.9M
Current Assets	TWD 1.5B
Current Liabilities	TWD 800M
Debt	TWD 731.9M
Debt EBITDA	TWD 4.04
Debt Equity	TWD 0.59
Debt FCF	TWD 5.73
Equity	TWD 1.2B
Interest Coverage	6.95
Liabilities	TWD 857.2M
Long Term Assets	TWD 570.3M
Long Term Liabilities	TWD 57.2M
Net Cash	TWD 122M
Net Cash By Market Cap	TWD 3.98
Net Cash Growth	268.93%
Net Debt EBITDA	TWD -0.69
Net Debt Equity	TWD -0.1
Net Debt FCF	TWD -0.96
Tangible Book Value	TWD 1.2B
Tangible Book Value Per Share	TWD 12.83
WACC	4.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.9
Inventory Turnover	1.04
Net Working Capital	TWD 560.9M
Quick ratio	1.24
Working Capital	TWD 721.4M
Working Capital Turnover	TWD 1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.1%
Dividend Growth	17.65%
Dividend Growth Years	1%
Dividend per share	TWD 1.25
Dividend Years	10
Dividend Yield	3.92%
Ex Div Date	2025-07-17
Last Dividend	TWD 1
Payout Frequency	Annual
Payout Ratio	74.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	193.01%
1Y total return	91.02%
200-day SMA	22.21
3Y total return	91.65%
50-day SMA	28.06
50-day SMA vs 200-day SMA	50over200
5Y total return	129.12%
All Time High	35.5
All Time High Change	-10.28%
All Time High Date	2026-04-22
All Time Low	8.6
All Time Low Change	270.35%
All Time Low Date	2011-12-26
ATR	1.3
Beta	0.12
Beta1y	0.08
Beta2y	0.22
Ch YTD	37.88
High	32.4
High52	35.5
High52 Date	2026-04-22
High52ch	-10.28%
Low	31.6
Low52	16.8
Low52 Date	2025-08-29
Low52ch	89.58%
Ma50ch	13.5%
Price vs 200-day SMA	43.4%
RSI	60.18
RSI Monthly	85.75
RSI Weekly	79.72
Sharpe ratio	1.94x
Sortino ratio	4.97
Total Return	3.83%
Tr YTD	37.88
Tr15y	325.06%
Tr1m	20.19%
Tr1w	-2.15%
Tr3m	28.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 120.3M
Operating Income Growth	36.57
Operating Income Growth Q	-15.17
Operating Income Growth3 Y	6.44
Operating Income Growth5 Y	3.25
Operating margin	14.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,061,110%
Net Borrowing	-224,036,000
Shares Insiders	9.11%
Shares Institutions	12.89%
Shares Out	96,243,000
Shares Qo Q	0.22%
Shares Yo Y	0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 127.6M
Average Volume	275,300x
Bv Per Share	12.83
CAPEX	TWD -89.5M
Ch10y	88.46
Ch15y	173.4
Ch1m	20.19
Ch1w	-2.15
Ch1y	80.97
Ch3m	28.95
Ch3y	61.68
Ch5y	77.44
Ch6m	75.48
Change	-0.47%
Change From Open	-1.7
Close	32
Days Gap	1.25
Depreciation Amortization	55,392,000
Dollar Volume	3,034,445.1
Earnings Date	2026-05-04
EBIT	TWD 120.3M
EBITDA	TWD 175.7M
EPS	TWD 1.34
F Score	8
FCF	TWD 127.6M
FCF EV Yield	4.34x
FCF Per Share	TWD 1.33
Financing CF	-319,332,000
Fiscal Year End	December
Founded	2,001
Graham Number	19.66638
Graham Upside	-38.25
Income Tax	TWD 34.7M
Investing CF	-89,488,000
Is Primary Listing	1
Last Earnings Date	2025-08-08
Last Report Date	2025-12-31
Lynch Fair Value	TWD 13.74
Lynch Upside	-56.87
Ma150	23.69
Ma150ch	34.47%
Ma20	30.56
Ma20ch	4.21%
Net CF	-189,250,000
Open	32.4
P FCF Ratio	24.02
P OCF Ratio	14.12
Payment Date	2025-08-14
Position In Range	31.25
Ppne	540,702,000
Price Date	2026-05-08
Price EBITDA	TWD 17.44
Ptbv Ratio	2.48
Relative Volume	0.35x
Revenue	849,507,000x
Tax By Revenue	4.08x
Tax Rate	21.12%
Tr6m	75.48%
Volume	95,273
Z Score	2.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/1780 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.9%

$1.25 annual per share

Payout ratio

+74.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.6%

1 consecutive years of growth

Total shareholder yield

+3.8%

Next ex-dividend date: 2025-07-17

Performance

TPEX/1780 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/1780?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.9%

Share of float held by funds and institutions

Insider ownership

+9.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

TPEX/1780 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.2

Neutral momentum band

Price vs 200-day MA

+43.4%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

1.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/1780

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/1780 stock rating?

tpex/1780 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/1780 analysis?

The full report lives at /stocks/tpex/1780/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/1780?

The latest report frames tpex/1780 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/1780 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.